Novel uses of ketamine in the emergency department

References

• Eldufani J, Nekoui A, Blaise G. Nonanesthetic effects of ketamine: a review article. Am J Med. 2018;131(12):1418–1424.
   PubMed Web of Science ®Google Scholar
• Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19(6):370–380.
   PubMed Web of Science ®Google Scholar
• Li L, Vlisides PE. Ketamine: 50 years of modulating the mind. Front Hum Neurosci. 2016;10(Nov 2016). DOI:10.3389/FNHUM.2016.00612
   Web of Science ®Google Scholar
• Peltoniemi MA, Hagelberg NM, Olkkola KT, et al. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55(9):1059–1077.
   PubMed Web of Science ®Google Scholar
• Sleigh J, Harvey M, Voss L, et al. Ketamine – more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4(2–3):76–81.
   Google Scholar
• Sheikh S, Hendry P. The expanding role of ketamine in the emergency department. Drugs. 2018;78(7):727–735.
   PubMed Web of Science ®Google Scholar
• Corriger A, Pickering G. Ketamine and depression: a narrative review. Drug Des Devel Ther. 2019;13:3051–3067.
   PubMed Web of Science ®Google Scholar
• Molero P, Ramos-Quiroga JA, Martin-Santos R, et al. Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review. CNS Drugs. 2018;32(5):411–420.
   PubMed Web of Science ®Google Scholar
• Motov S, Rockoff B, Cohen V, et al. Intravenous subdissociative-dose ketamine versus morphine for analgesia in the emergency department: a randomized controlled trial. Acta parasitologica. 2015 [cited 2015 Nov 27];66(3):222–229.E1. Available from: https://pubmed.ncbi.nlm.nih.gov/25817884/
   Google Scholar
• McKinley K, Panakos P, Yousef D. Characterization of ketamine usage in a large tertiary-care emergency department. Am J Emerg Med. 2021;47:149–153.
   PubMed Web of Science ®Google Scholar
• Motov S, Mann S, Drapkin J, et al. Intravenous subdissociative-dose ketamine versus morphine for acute geriatric pain in the emergency department: a randomized controlled trial. Am J Emerg Med. 2019;37(2):220–227.
   PubMed Web of Science ®Google Scholar
• Riddell J, Tran A, Bengiamin R, et al. Ketamine as a first-line treatment for severely agitated emergency department patients. Am J Emerg Med. 2017;35(7):1000–1004.
   PubMed Web of Science ®Google Scholar
• Barbic D, Andolfatto G, Grunau B, et al. Rapid agitation control with ketamine in the emergency department: a blinded, randomized controlled trial. Ann Emerg Med. 2021;78(6):788–795.
   PubMed Web of Science ®Google Scholar
• Murrough JW, Perez AM, Pillemer S, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74(4):250–256.
   PubMed Web of Science ®Google Scholar
• DiazGranados N, Ibrahim LA, Brutsche NE, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry. 2010;71(12):1605–1611.
   PubMed Web of Science ®Google Scholar
• Botanas CJ, De La Peña JB, Dela Peña IJ, et al. Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: evidence of its abuse potential. Pharmacol Biochem Behav. 2015;133:31–36.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lin D, Wu B, et al. Ketamine abuse potential and use disorder. Brain Res Bull. 2016;126(Pt 1):68–73.
   PubMedGoogle Scholar
• Zanos P, Moaddel R, Morris PJ, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70(3):621–660.
   PubMed Web of Science ®Google Scholar
• Zorumski CF, Izumi Y, Mennerick S. Ketamine: NMDA receptors and beyond. J Neurosci. 2016;36(44):11158–11164.
   PubMed Web of Science ®Google Scholar
• Orser BA, Pennefather PS, MacDonald JF. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 1997;86(4):903–917.
   PubMed Web of Science ®Google Scholar
• Lanthorn TH, Mealing GAR, Morley P. Differences in degree of trapping between AR-R15896 and other uncompetitive NMDA receptor antagonists. Amino Acids. 2000;19(1):173–175.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ. Metabolism and metabolomics of ketamine: a toxicological approach. Forensic Sci Res. 2017;2(1):2–10.
   PubMed Web of Science ®Google Scholar
• Zhou C, Douglas JE, Kumar NN, et al. Forebrain HCN1 channels contribute to hypnotic actions of ketamine. Anesthesiology. 2013;118(4):785–795.
   PubMed Web of Science ®Google Scholar
• Chen X, Shu S, Bayliss DA. HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine. J Neurosci. 2009;29(3):600–609.
   PubMed Web of Science ®Google Scholar
• Green SM, Krauss B. Ketamine is a safe, effective, and appropriate technique for emergency department paediatric procedural sedation. Emerg Med J. 2004;21(3):271–272.
   PubMed Web of Science ®Google Scholar
• Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature. 1984;309(5965):261–263.
   PubMed Web of Science ®Google Scholar
• Petrenko AB, Yamakura T, Sakimura K, et al. Defining the role of NMDA receptors in anesthesia: are we there yet? Eur J Pharmacol. 2014;723(1):29–37.
   PubMedGoogle Scholar
• Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.
   PubMed Web of Science ®Google Scholar
• Gupta A, Devi LA, Gomes I. Potentiation of μ-opioid receptor-mediated signaling by ketamine. J Neurochem. 2011;119(2):294–302.
   PubMed Web of Science ®Google Scholar
• Hustveit O, Maurset A, Øye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, σ and muscarinic receptors. Toxicol Pharmacol. 1995;77(6):355–359.
   PubMedGoogle Scholar
• Martinotti G, Chiappini S, Pettorruso M, et al. Therapeutic potentials of ketamine and esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): a review of the current literature. Brain Sci. 2021;11(7):856.
   PubMed Web of Science ®Google Scholar
• Krystal JH, Abdallah CG, Sanacora G, et al. Ketamine: a paradigm shift for depression research and treatment. Neuron. 2019;101(5):774–778.
   PubMed Web of Science ®Google Scholar
• Hashimoto K. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Biochem Pharmacol. 2020;177:113935.
   PubMed Web of Science ®Google Scholar
• Zanos P, Moaddel R, Morris PJ, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nat. 2016;533(7604):481–486.
   Google Scholar
• Newport DJ, Carpenter LL, McDonald WM, et al. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am J Psychiatry. 2015;172(10):950–966.
   PubMed Web of Science ®Google Scholar
• Hashimoto K. Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin Neurosci. 2019;73(10):613–627.
   PubMed Web of Science ®Google Scholar
• Zhang JC, Li SX, Hashimoto K. R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine. Pharmacol Biochem Behav. 2014;116:137–141.
   PubMed Web of Science ®Google Scholar
• Wei Y, Chang L, Hashimoto K. A historical review of antidepressant effects of ketamine and its enantiomers. Pharmacol Biochem Behav. 2020;190:172870.
   PubMed Web of Science ®Google Scholar
• Malinow R. Depression: ketamine steps out of the darkness. Nature. 2016;533(7604):477–478.
   PubMed Web of Science ®Google Scholar
• Maeng S, Zarate CA, Du J, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008;63(4):349–352.
   PubMed Web of Science ®Google Scholar
• Yang C, Yang J, Luo A, et al. Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites. Transl Psychiatry. 2019;9(1):1–11.
   PubMedGoogle Scholar
• Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015;11(6):1164–1178.
   PubMed Web of Science ®Google Scholar
• Garcia LSB, Comim CM, Valvassori SS, et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuro Psychopharmacol Biol Psychiatry. 2008;32(1):140–144.
   PubMed Web of Science ®Google Scholar
• Fanta S, Kinnunen M, Backman JT, et al. Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing. Eur J Clin Pharmacol. 2015;71(4):441–447.
   PubMed Web of Science ®Google Scholar
• Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci. 1982;71(5):539–542.
   PubMed Web of Science ®Google Scholar
• Yanagihara Y, Ohtani M, Kariya S, et al. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharm Drug Dispos. 2003;24(1):37–43.
   PubMed Web of Science ®Google Scholar
• Weber F, Wulf H, Gruber M, et al. S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children. Paediatr Anaesth. 2004;14(12):983–988.
   PubMed Web of Science ®Google Scholar
• Scheppke KA, Braghiroli J, Shalaby M, et al. Prehospital use of i.m. ketamine for sedation of violent and agitated patients. West J Emerg Med. 2014;15(7):736–741.
   PubMedGoogle Scholar
• Green SM, Roback MG, Kennedy RM, et al. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57(5):449–461.
   PubMed Web of Science ®Google Scholar
• Scaggs TR, Glass DM, Hutchcraft MG, et al. Prehospital ketamine is a safe and effective treatment for excited delirium in a community hospital based EMS system. Prehosp Disaster Med. 2016;31(5):563–569.
   PubMed Web of Science ®Google Scholar
• Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol. 2008;182(182):313–333.
   Google Scholar
• Sassano-Higgins S, Baron D, Juarez G, et al. A review of ketamine abuse and diversion. Depress Anxiety. 2016;33(8):718–727.
   PubMed Web of Science ®Google Scholar
• Motov S, Strayer R, Hayes BD, et al. The treatment of acute pain in the emergency department: a white paper position statement prepared for the American academy of emergency medicine. J Emerg Med. 2018;54(5):731–736.
   PubMed Web of Science ®Google Scholar
• ACEP // Sub-dissociative dose ketamine for analgesia. [cited 2021 Nov 28]. Available from: https://www.acep.org/patient-care/policy-statements/sub-dissociative-dose-ketamine-for-analgesia/
   Google Scholar
• Kurdi M, Theerth K, Deva R. Ketamine: current applications in anesthesia, pain, and critical care. Anesth Essays Res. 2014;8(3):283.
   PubMedGoogle Scholar
• Bennett GJ. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage. 2000;19:2–6.
   PubMed Web of Science ®Google Scholar
• Raja SN, Sivanesan E, Guan Y. Central sensitization, N -methyl- d -aspartate receptors, and human experimental pain models. Anesthesiology. 2019;131(2):233–235.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Naono R, Ikeda T, et al. NMDA and AMPA receptors contribute to the maintenance of substance P-induced thermal hyperalgesia. Neurosci Res. 2010;67(1):18–24.
   PubMed Web of Science ®Google Scholar
• Herrero JF, Laird JMA, Lopez-Garcia JA. Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol. 2000;61(2):169–203.
   PubMed Web of Science ®Google Scholar
• Sigtermans M, Noppers I, Sarton E, et al. An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in complex regional pain syndrome type 1 patients. Eur J Pain. 2010;14(3):302–307.
   PubMed Web of Science ®Google Scholar
• Dahan A, Olofsen E, Sigtermans M, et al. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur J Pain. 2011;15(3):258–267.
   PubMed Web of Science ®Google Scholar
• Johansson P, Kongstad P, Johansson A. The effect of combined treatment with morphine sulphate and low-dose ketamine in a prehospital setting. Scand J Trauma Resusc Emerg Med. 2009;17(1):61.
   PubMedGoogle Scholar
• Jennings PA, Cameron P, Bernard S, et al. Morphine and ketamine is superior to morphine alone for out-of-hospital trauma analgesia: a randomized controlled trial. Ann Emerg Med. 2012;59(6):497–503.
   PubMed Web of Science ®Google Scholar
• Ahern TL, Herring AA, Anderson ES, et al. The first 500: initial experience with widespread use of low-dose ketamine for acute pain management in the ED. Am J Emerg Med. 2015;33(2):197–201.
   PubMed Web of Science ®Google Scholar
• Miller JP, Schauer SG, Ganem VJ, et al. Low-dose ketamine vs morphine for acute pain in the ED: a randomized controlled trial. Am J Emerg Med. 2015;33(3):402–408.
   PubMed Web of Science ®Google Scholar
• Goltser A, Soleyman-Zomalan E, Kresch F, et al. Short (low-dose) ketamine infusion for managing acute pain in the ED: case-report series. Am J Emerg Med. 2015;33(4):601.e5–601.e7.
   Web of Science ®Google Scholar
• Motov S, Mai M, Pushkar I, et al. A prospective randomized, double-dummy trial comparing IV push low dose ketamine to short infusion of low dose ketamine for treatment of pain in the ED. Am J Emerg Med. 2017;35(8):1095–1100.
   PubMed Web of Science ®Google Scholar
• Ahern TL, Herring AA, Miller S, et al. Low-dose ketamine infusion for emergency department patients with severe pain. Pain Med. 2015;16(7):1402–1409.
   PubMed Web of Science ®Google Scholar
• Motov S, Drapkin J, Likourezos A, et al. Continuous intravenous sub-dissociative dose ketamine infusion for managing pain in the emergency department. West J Emerg Med. 2018;19(3):559–566.
   PubMed Web of Science ®Google Scholar
• Andolfatto G, Willman E, Joo D, et al. Intranasal ketamine for analgesia in the emergency department: a prospective observational series. Acad Emerg Med. 2013;20(10):1050–1054.
   PubMed Web of Science ®Google Scholar
• Drapkin J, Masoudi A, Butt M, et al. Administration of nebulized ketamine for managing acute pain in the emergency department: a case series. Clin Pract Cases Emerg Med. 2020;4(1):16–20.
   PubMedGoogle Scholar
• Fassassi C, Dove D, Davis AR, et al. Nebulized ketamine used for pain management of orthopedic trauma. J Emerg Med. 2021;60(3):365–367.
   PubMed Web of Science ®Google Scholar
• Gurnani A, Sharma PK, Rautela RS, et al. Analgesia for acute musculoskeletal trauma: low-dose subcutaneous infusion of ketamine. Anaesth Intensive Care. 1996;24(1):32–36.
   PubMed Web of Science ®Google Scholar
• Lintner AC, Brennan P, Miles MVP, et al. Oral administration of injectable ketamine during burn wound dressing changes. J Pharm Pract. 2021;34(3):423–427.
   PubMed Web of Science ®Google Scholar
• Dove D, Fassassi C, Davis A, et al. Comparison of nebulized ketamine at three different dosing regimens for treating painful conditions in the emergency department: a prospective, randomized, double-blind clinical trial. Ann Emerg Med. 2021:1–9. Published online. DOI:10.1016/j.annemergmed.2021.04.031
   Web of Science ®Google Scholar
• Grant IS, Nimmo WS, Clements JA. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth. 1981;53(8):805–810.
   PubMed Web of Science ®Google Scholar
• Wang X, Lin C, Lan L, et al. Perioperative intravenous S-ketamine for acute postoperative pain in adults: a systematic review and meta-analysis. J Clin Anesth. 2021;68. DOI:10.1016/j.jclinane.2020.110071
   Web of Science ®Google Scholar
• Wang P, Yang Z, Shan S, et al. Analgesic effect of perioperative ketamine for total hip arthroplasties and total knee arthroplasties: a PRISMA-compliant meta-analysis. Medicine (Baltimore). 2020;99(42). DOI:10.1097/MD.0000000000022809
   Web of Science ®Google Scholar
• Chitneni A, Patil A, Dalal S, et al. Use of ketamine infusions for treatment of complex regional pain syndrome: a systematic review. Cureus. 2021; Published online. doi:10.7759/cureus.18910
   Web of Science ®Google Scholar
• Harris EM, Vilk E, Heeney MM, et al. A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease. Pediatr Blood Cancer. 2021;68(7). DOI:10.1002/pbc.28989
   Web of Science ®Google Scholar
• Sandberg M, Hyldmo PK, Kongstad P, et al. Ketamine for the treatment of prehospital acute pain: a systematic review of benefit and harm. BMJ Open. 2020;10(11):e038134.
   PubMed Web of Science ®Google Scholar
• Balzer N, McLeod SL, Walsh C, et al. Low-dose ketamine for acute pain control in the emergency department: a systematic review and meta-analysis. Acad Emerg Med. 2021;28(4):444–454.
   PubMed Web of Science ®Google Scholar
• Beaudoin FL, Lin C, Guan W, et al. Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial. Acad Emerg Med. 2014;21(11):1193–1202.
   PubMed Web of Science ®Google Scholar
• Bowers KJ, McAllister KB, Ray M, et al. Ketamine as an adjunct to opioids for acute pain in the emergency department: a randomized controlled trial. Acad Emerg Med. 2017;24(6):676–685.
   PubMed Web of Science ®Google Scholar
• Sotoodehnia M, Farmahini-Farahani M, Safaie A, et al. Low-dose intravenous ketamine versus intravenous ketorolac in pain control in patients with acute renal colic in an emergency setting: a double-blind randomized clinical trial. Korean J Pain. 2019;32(2):97–104.
   PubMed Web of Science ®Google Scholar
• Lovett S, Reed T, Riggs R, et al. A randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department. Acad Emerg Med. 2021;28(6):647–654.
   PubMed Web of Science ®Google Scholar
• Clattenburg EJ, Hailozian C, Haro D, et al. Slow infusion of low-dose ketamine reduces bothersome side effects compared to intravenous push: a double-blind, double-dummy, randomized controlled trial. Acad Emerg Med. 2018;25(9):1048–1052.
   PubMed Web of Science ®Google Scholar
• Schwenk ES, Viscusi ER, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):456–466.
   PubMed Web of Science ®Google Scholar
• Yeaman F, Meek R, Egerton-Warburton D, et al. Sub-dissociative-dose intranasal ketamine for moderate to severe pain in adult emergency department patients. Emerg Med Australas. 2014;26(3):237–242.
   PubMed Web of Science ®Google Scholar
• Shimonovich S, Gigi R, Shapira A, et al. Intranasal ketamine for acute traumatic pain in the emergency department: a prospective, randomized clinical trial of efficacy and safety. BMC Emerg Med. 2016;16(1). DOI:10.1186/S12873-016-0107-0
   PubMedGoogle Scholar
• Yeaman F, Oakley E, Meek R, et al. Sub-dissociative dose intranasal ketamine for limb injury pain in children in the emergency department: a pilot study. Emerg Med Australas. 2013;25(2):161–167.
   PubMed Web of Science ®Google Scholar
• Graudins A, Meek R, Egerton-Warburton D, et al. The PICHFORK (Pain in children fentanyl or ketamine) trial: a randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to severe pain in children with limb injuries. Ann Emerg Med. 2015;65(3):248–254.e1.
   PubMed Web of Science ®Google Scholar
• Reynolds SL, Bryant KK, Studnek JR, et al. Randomized controlled feasibility trial of intranasal ketamine compared to intranasal fentanyl for analgesia in children with suspected extremity fractures. Acad Emerg Med. 2017;24(12):1430–1440.
   PubMed Web of Science ®Google Scholar
• Frey TM, Florin TA, Caruso M, et al. Effect of intranasal ketamine vs fentanyl on pain reduction for extremity injuries in children: the PRIME randomized clinical trial. JAMA Pediatr. 2019;173(2):140–146.
   PubMed Web of Science ®Google Scholar
• Oliveira J, e Silva L, Lee JY, et al. Intranasal ketamine for acute pain management in children: a systematic review and meta-analysis. Am J Emerg Med. 2020;38(9):1860–1866.
   PubMed Web of Science ®Google Scholar
• Seak YS, Nor J, Kamauzaman THT, et al. Efficacy and safety of intranasal ketamine for acute pain management in the emergency setting: a systematic review and meta-analysis. J Clin Med. 2021;10(17):3978.
   PubMed Web of Science ®Google Scholar
• Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–1006.
   PubMed Web of Science ®Google Scholar
• Noppers I, Niesters M, Aarts L, et al. Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother. 2010;11(14):2417–2429.
   PubMed Web of Science ®Google Scholar
• Bredlau AL, Thakur R, Korones DN, et al. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med. 2013;14(10):1505–1517.
   PubMed Web of Science ®Google Scholar
• Alshahrani MS, AlSulaibikh AH, ElTahan MR, et al. Ketamine administration for acute painful sickle cell crisis: a randomized controlled trial. Acad Emerg Med. 2021;29(2):150–158.
   PubMed Web of Science ®Google Scholar
• Brandow AM, Carroll CP, Creary S, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020;4(12):2656–2701.
   PubMed Web of Science ®Google Scholar
• Alshahrani M, Alghamdi M. Ketamine for sickle cell vaso-occlusive crises: a systematic review. Saudi J Med Med Sci. 2021;9(1):3.
   PubMed Web of Science ®Google Scholar
• Strayer RJ, Motov SM, Nelson LS. Something for pain: responsible opioid use in emergency medicine. Am J Emerg Med. 2017;35(2):337–341.
   PubMed Web of Science ®Google Scholar
• Weinbroum AA. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg. 2003;96(3):789–795.
   PubMed Web of Science ®Google Scholar
• Lester L, Braude DA, Niles C, et al. Low-dose ketamine for analgesia in the ED: a retrospective case series. Am J Emerg Med. 2010;28(7):820–827.
   PubMed Web of Science ®Google Scholar
• Strayer RJ, Hawk K, Hayes BD, et al. Management of opioid use disorder in the emergency department: a white paper prepared for the American Academy of Emergency Medicine. J Emerg Med. 2020;58(3):522–546.
   PubMed Web of Science ®Google Scholar
• Haller G, Waeber JL, Infante NK, et al. Ketamine combined with morphine for the management of pain in an opioid addict. Anesthesiology. 2002;96(5):1265–1266.
   PubMed Web of Science ®Google Scholar
• Miner JR. Ketamine is a good first-line option for severely agitated patients in the prehospital environment. Am J Emerg Med. 2018;36(3):501–502.
   PubMed Web of Science ®Google Scholar
• Miner JR, Klein LR, Cole JB, et al. The characteristics and prevalence of agitation in an urban county emergency department. Ann Emerg Med. 2018;72(4):361–370.
   PubMed Web of Science ®Google Scholar
• Kim HK, Leonard JB, Corwell BN, et al. Safety and efficacy of pharmacologic agents used for rapid tranquilization of emergency department patients with acute agitation or excited delirium. Expert Opin Drug Saf. 2021;20(2):123–138.
   PubMed Web of Science ®Google Scholar
• Workplace Violence in Healthcare. 2018. [cited 2021 Nov 28]. Available from: https://www.bls.gov/iif/oshwc/cfoi/workplace-violence-healthcare-2018.htm
   Google Scholar
• Moritz F, Clarot F, Muller JM, et al. Toxicological analysis in agitated patients. Intensive Care Med. 1999;25(8):852–854.
   PubMed Web of Science ®Google Scholar
• Gonin P, Beysard N, Yersin B, et al. Excited delirium: a systematic review. Acad Emerg Med. 2018;25(5):552–565.
   PubMed Web of Science ®Google Scholar
• Cole JB, Moore JC, Nystrom PC, et al. A prospective study of ketamine versus haloperidol for severe prehospital agitation. Clin Toxicol (Phila). 2016;54(7):556–562.
   PubMed Web of Science ®Google Scholar
• Kowalski JM, Kopec KT, Lavelle J, et al. A novel agent for management of agitated delirium: a case series of ketamine utilization in the pediatric emergency department. Pediatr Emerg Care. 2017;33(9):e58–e62.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Calver LA, Downes MA, et al. Ketamine as rescue treatment for difficult-to-sedate severe acute behavioral disturbance in the emergency department. Ann Emerg Med. 2016;67(5):581–587.e1.
   PubMed Web of Science ®Google Scholar
• Cole JB, Klein LR, Nystrom PC, et al. A prospective study of ketamine as primary therapy for prehospital profound agitation. Am J Emerg Med. 2018;36(5):789–796.
   PubMed Web of Science ®Google Scholar
• Hopper AB, Vilke GM, Castillo EM, et al. Ketamine use for acute agitation in the emergency department. J Emerg Med. 2015;48(6):712–719.
   PubMed Web of Science ®Google Scholar
• Melamed E, Oron Y, Ben-Avraham R, et al. The combative multitrauma patient: a protocol for prehospital management. Eur J Emerg Med. 2007;14(5):265–268.
   PubMed Web of Science ®Google Scholar
• Olives TD, Nystrom PC, Cole JB, et al. Intubation of profoundly agitated patients treated with prehospital ketamine. Prehosp Disaster Med. 2016;31(6):593–602.
   PubMed Web of Science ®Google Scholar
• Gottlieb M, Long B, Koyfman A. Approach to the agitated emergency department patient. J Emerg Med. 2018;54(4):447–457.
   PubMed Web of Science ®Google Scholar
• Heydari F, Gholamian A, Zamani M, et al. Effect of intramuscular ketamine versus haloperidol on short-term control of severe agitated patients in emergency department; a randomized clinical trial. Bull Emerg Trauma. 2018;6(4):292–299.
   PubMedGoogle Scholar
• Sullivan N, Chen C, Siegel R, et al. Ketamine for emergency sedation of agitated patients: a systematic review and meta-analysis. Am J Emerg Med. 2020;38(3):655–661.
   PubMed Web of Science ®Google Scholar
• Li M, Martinelli AN, Oliver WD, et al. Evaluation of ketamine for excited delirium syndrome in the adult emergency department. J Emerg Med. 2019;58(1):100–105.
   Web of Science ®Google Scholar
• Mankowitz SL, Regenberg P, Kaldan J, et al. Ketamine for rapid sedation of agitated patients in the prehospital and emergency department settings: a systematic review and proportional meta-analysis. J Emerg Med. 2018;55(5):670–681.
   PubMed Web of Science ®Google Scholar
• Kirkup CT, Bennett J. Chapter 32 – the pharmacology of ketamine and its use in outpatient anesthesia. Undefined. 2012; 264–270. Published online. DOI: 10.1016/B978-1-4160-2527-6.00032-3
   Google Scholar
• Keseg D, Cortez E, Rund D, et al. The use of prehospital ketamine for control of agitation in a metropolitan firefighter-based EMS system. Prehosp Emerg Care. 2015;19(1):110–115.
   PubMed Web of Science ®Google Scholar
• Burnett AM, Salzman JG, Griffith KR, et al. The emergency department experience with prehospital ketamine: a case series of 13 patients. Prehosp Emerg Care. 2012;16(4):553–559.
   PubMed Web of Science ®Google Scholar
• O’Connor L, Rebesco M, Robinson C, et al. Outcomes of prehospital chemical sedation with ketamine versus haloperidol and benzodiazepine or physical restraint only. Prehosp Emerg Care. 2019;23(2):201–209.
   PubMed Web of Science ®Google Scholar
• Cunningham C, Gross K, Broach JP, et al. Patient outcomes following ketamine administration for acute agitation with a decreased dosing protocol in the prehospital setting. Prehosp Disaster Med. 2021;36(3):276–282.
   PubMed Web of Science ®Google Scholar
• Burnett AM, Peterson BK, Stellpflug SJ, et al. The association between ketamine given for prehospital chemical restraint with intubation and hospital admission. Am J Emerg Med. 2015;33(1):76–79.
   PubMed Web of Science ®Google Scholar
• Parsch CS, Boonstra A, Teubner D, et al. Ketamine reduces the need for intubation in patients with acute severe mental illness and agitation requiring transport to definitive care: an observational study. Emerg Med Australas. 2017;29(3):291–296.
   PubMed Web of Science ®Google Scholar
• Hanjie M, Campbell Matthew J, Fertel Baruch S, et al. Ketamine safety and use in the emergency department for pain and agitation/delirium: a health system experience. West J Emerg Med. 2020;21(2):281.
   Web of Science ®Google Scholar
• Linder LM, Ross CA, Weant KA. Ketamine for the acute management of excited delirium and agitation in the prehospital setting. Pharmacotherapy. 2018;38(1):139–151.
   PubMed Web of Science ®Google Scholar
• Fernandez AR, Bourn SS, Crowe RP, et al. Out-of-hospital ketamine: indications for use, patient outcomes, and associated mortality. Ann Emerg Med. 2021;78(1):123–131.
   PubMed Web of Science ®Google Scholar
• Le Cong M, Humble I. A ketamine protocol and intubation rates for psychiatric air medical retrieval. Air Med J. 2015;34(6):357–359.
   PubMedGoogle Scholar
• Nazarian DJ, Broder JS, Thiessen MEW, et al. Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Ann Emerg Med. 2017;69(4):480–498.
   PubMed Web of Science ®Google Scholar
• Nordstrom K, Berlin JS, Nash SS, et al. Boarding of mentally Ill patients in emergency departments: American Psychiatric Association resource document. West J Emerg Med. 2019;20(5):690–695.
   PubMed Web of Science ®Google Scholar
• Nash KA, Zima BT, Rothenberg C, et al. Prolonged emergency department length of stay for US pediatric mental health visits (2005-2015). Pediatrics. 2021;147(5). DOI:10.1542/PEDS.2020-030692
   Web of Science ®Google Scholar
• Moore BJ, Stocks C, Owens PL Trends in emergency department visits, 2006-2014. Published online 2006 [cited 2021 Nov 28]. Available from: www.hcupnet.ahrq.gov/
   Google Scholar
• Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351–354.
   PubMed Web of Science ®Google Scholar
• Andrade C. Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency? J Clin Psychiatry. 2017;78(7):e852–e857.
   PubMed Web of Science ®Google Scholar
• Frazer A, Benmansour S. Delayed pharmacological effects of antidepressants. Mol Psychiatry. 2002;7(Suppl 1):S23–S28.
   PubMedGoogle Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–1917.
   PubMed Web of Science ®Google Scholar
• Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856–864.
   PubMed Web of Science ®Google Scholar
• Diazgranados N, Ibrahim L, Brutsche NE, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. 2010;67(8):793–802.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Byrow Y, Cassidy F, et al. Ketamine: stimulating antidepressant treatment? BJPsych Open. 2016;2(3):e5–e9.
   PubMedGoogle Scholar
• Dean RL, Hurducas C, Hawton K, et al. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder. Cochrane Database Syst Rev. 2021;9(9). DOI:10.1002/14651858.CD011612.PUB3
   PubMedGoogle Scholar
• Murrough JW, Iosifescu DV, Chang LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013;170(10):1134–1142.
   PubMed Web of Science ®Google Scholar
• Singh JB, Fedgchin M, Daly EJ, et al. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry. 2016;173(8):816–826.
   PubMed Web of Science ®Google Scholar
• Wilkowska A, Włodarczyk A, Gałuszko-Węgielnik M, et al. Intravenous ketamine infusions in treatment-resistant bipolar depression: an open-label naturalistic observational study. Neuropsychiatr Dis Treat. 2021;17:2637–2646.
   PubMed Web of Science ®Google Scholar
• Zheng W, Zhou YL, Liu WJ, et al. A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression. J Affect Disord. 2020;275:38–43.
   PubMed Web of Science ®Google Scholar
• Caddy C, Amit BH, Mccloud TL, et al. Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev. 2015;2015(9). DOI:10.1002/14651858.CD011612.PUB2
   Google Scholar
• Cavenaghi VB, da Costa LP, Lacerda ALT, et al. Subcutaneous ketamine in depression: a systematic review. Front Psychiatry. 2021;12. DOI:10.3389/FPSYT.2021.513068
   Web of Science ®Google Scholar
• Lapidus KAB, Levitch CF, Perez AM, et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry. 2014;76(12):970–976.
   PubMed Web of Science ®Google Scholar
• Yang S, Wang J, Li X, et al. Adverse effects of esketamine for the treatment of major depression disorder: findings from randomized controlled trials. Psychiatr Q. 2021;93(1):81–95.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality (AHRQ). Emergency department visits related to suicidal ideation or suicide attempt, 2008-2017. Published 2020 [cited 2022 Mar 11]. Available from: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb263-Suicide-ED-Visits-2008-2017.jsp
   Google Scholar
• Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA. 2004;292(3):338–343.
   PubMed Web of Science ®Google Scholar
• Price RB, Nock MK, Charney DS, et al. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry. 2009;66(5):522–526.
   PubMed Web of Science ®Google Scholar
• Wilkinson ST, Ballard ED, Bloch MH, et al. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry. 2018;175(2):150–158.
   PubMed Web of Science ®Google Scholar
• Ballard ED, Ionescu DF, Vande Voort JL, et al. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res. 2014;58:161–166.
   PubMed Web of Science ®Google Scholar
• Canuso CM, Singh JB, Fedgchin M, et al. Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 2018;175(7):620–630.
   PubMed Web of Science ®Google Scholar
• Mathew SJ, Shah A, Lapidus K, et al. Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs. 2012;26(3):189–204.
   PubMed Web of Science ®Google Scholar
• Domany Y, Shelton RC, McCullumsmith CB. Ketamine for acute suicidal ideation. An emergency department intervention: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Depress Anxiety. 2020;37(3):224–233.
   PubMed Web of Science ®Google Scholar
• Burger J, Capobianco M, Lovern R, et al. A double-blinded, randomized, placebo-controlled sub-dissociative dose ketamine pilot study in the treatment of acute depression and suicidality in a military emergency department setting. Mil Med. 2016;181(10):1195–1199.
   PubMed Web of Science ®Google Scholar
• Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA psychiatry. 2017;74(4):399–405.
   PubMed Web of Science ®Google Scholar
• Nichols KA, Paciullo CA. Subdissociative ketamine use in the emergency department. Adv Emerg Nurs J. 2019;41(1):15–22.
   PubMed Web of Science ®Google Scholar
• Pourmand A, Mazer-Amirshahi M, Royall C, et al. Low dose ketamine use in the emergency department, a new direction in pain management. Am J Emerg Med. 2017;35(6):918–921.
   PubMedGoogle Scholar
• Andolfatto G, Innes K, Dick W, et al. Prehospital analgesia with intranasal ketamine (PAIN-K): a randomized double-blind trial in adults. Ann Emerg Med. 2019;74(2):241–250.
   PubMed Web of Science ®Google Scholar
• Sener S, Eken C, Schultz CH, et al. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med. 2011;57(2):109–114.e2.
   PubMed Web of Science ®Google Scholar
• Sin B, Tatunchak T, Paryavi M, et al. The use of ketamine for acute treatment of pain: a randomized, double-blind, placebo-controlled trial. J Emerg Med. 2017;52(5):601–608.
   PubMed Web of Science ®Google Scholar
• Lahti AC, Koffel B, Laporte D, et al. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 1995;13(1):9–19.
   PubMed Web of Science ®Google Scholar
• Lebin JA, Akhavan AR, Hippe DS, et al. Psychiatric outcomes of patients with severe agitation following administration of prehospital ketamine. Acad Emerg Med. 2019;26(8):889–896.
   PubMed Web of Science ®Google Scholar
• Chudnofsky CR, Weber JE, Stoyanoff PJ, et al. A combination of midazolam and ketamine for procedural sedation and analgesia in adult emergency department patients. Acad Emerg Med. 2000;7(3):228–235.
   PubMed Web of Science ®Google Scholar
• Wan LB, Levitch CF, Perez AM, et al. Ketamine safety and tolerability in clinical trials for treatment-resistant depression. J Clin Psychiatry. 2015;76(3):247–252.
   PubMed Web of Science ®Google Scholar
• Green SM, Andolfatto G, Krauss BS. Ketamine and intracranial pressure: no contraindication except hydrocephalus. Ann Emerg Med. 2015;65(1):52–54.
   PubMed Web of Science ®Google Scholar
• Loflin R, Koyfman A. When used for sedation, does ketamine increase intracranial pressure more than fentanyl or sufentanil? Ann Emerg Med. 2015;65(1):55–56.
   PubMed Web of Science ®Google Scholar
• Zeiler FA, Teitelbaum J, West M, et al. The ketamine effect on intracranial pressure in nontraumatic neurological illness. J Crit Care. 2014;29(6):1096–1106.
   PubMed Web of Science ®Google Scholar
• Bourgoin A, Albanèse J, Wereszczynski N, et al. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med. 2003;31(3):711–717.
   PubMed Web of Science ®Google Scholar
• Weant KA, Davis WD, Davis KA, et al. The use of ketamine for the management of acute pain in the emergency department. Adv Emerg Nurs J. 2019;41(2):111–121.
   PubMed Web of Science ®Google Scholar
• Darke S, Duflou J, Farrell M, et al. Characteristics and circumstances of death related to the self-administration of ketamine. Addiction. 2021;116(2):339–345.
   PubMed Web of Science ®Google Scholar
• Gill JR, Stajíc M. Ketamine in non-hospital and hospital deaths in New York city. J Forensic Sci. 2000;45(3):14742J.
   Web of Science ®Google Scholar
• Kalsi SS, Wood DM, Dargan PI. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J. 2011;4(1). DOI:10.3402/ehtj.v4i0.7107
   PubMedGoogle Scholar
• Wood D, Bishop C, Greene S, et al. Ketamine-related toxicology presentations to the ED [abstract]. Clin Toxicol. 2008;46:630.
   Web of Science ®Google Scholar
• Pavarin RM, Marani S, Turino E. Ketamine abusers referring to emergency departments in northern Italy: a cross-sectional study. Ann Ist Super Sanita. 2019;55(4):338–344.
   PubMed Web of Science ®Google Scholar
• Ni A, Lee Cantrell F, Clark RF. Ketamine exposure demographics and outcomes over 16 years as reported to US poison centers. Am J Emerg Med. 2018;36(8):1459–1462.
   PubMed Web of Science ®Google Scholar
• Wolff K, Winstock AR. Ketamine: from medicine to misuse. CNS Drugs. 2006;20(3):199–218.
   PubMed Web of Science ®Google Scholar
• Lankenau SE, Sanders B, Bloom JJ, et al. Prevalence and patterns of prescription drug misuse among young ketamine injectors. J Drug Issues. 2007;37(3):717–735.
   PubMed Web of Science ®Google Scholar